Coeptis completes reverse merger with Z Squared; shares to trade as ZSQR April 27

Z Squared Inc.

Coeptis Therapeutics completes business combination with computing infrastructure firm Z Squared Inc.
Combined entity renamed Z Squared Inc.; shares to trade on Nasdaq Global Market under ZSQR starting April 27, 2026.
Prior to close, Coeptis distributed its biopharmaceutical business to its stockholders via pro rata distribution.
Post-merger: ~51.5M shares outstanding; former Z Squared stockholders own ~85%, legacy Coeptis holders own ~15%.
Z Squared COO cites vertically integrated platform across three states with dynamic power management and hardware lifecycle program.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001683168-26-003199
form_type: 8-K
ticker: ZSQR
cik: 0001759186
company_name: Z Squared Inc.
filed_at: 2026-04-24T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.864612+00:00
generated_at: 2026-05-15T04:13:07.187567+00:00
sec_items: ["7.01", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001683168-26-003199
json_url: https://secwatch.observer/filing/0001683168-26-003199.json
markdown_url: https://secwatch.observer/filing/0001683168-26-003199.md
text_url: https://secwatch.observer/filing/0001683168-26-003199.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/0001683168-26-003199-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/coeptis_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001683168-26-003199

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.